Innovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substances

Simple item page
dc.contributor.authorCosta, Paula
dc.contributor.authorAdvinha, Ana Margarida
dc.contributor.authorOliveira-Martins, Sofia
dc.date.accessioned2026-02-13T14:57:48Z
dc.date.available2026-02-13T14:57:48Z
dc.date.issued2024
dc.description.abstractInnovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substancespor
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.citationCosta P, Advinha AM, Oliveira-Martins S. Innovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substances. In: Abstracts of the 5th Annual Summit of the Comprehensive Health Research Centre (CHRC). Évora, Portugal: Port J Public Health, 42(suppl2); 2024. pp.11.por
dc.identifier.doihttps://doi.org/10.1159/000542309por
dc.identifier.urihttps://karger.com/pjp/article/42/Suppl.%202/1/916273/Book-of-abstracts-of-the-5th-CHRC-Annual-Summit
dc.identifier.urihttp://hdl.handle.net/10174/41146
dc.language.isoporpor
dc.peerreviewednopor
dc.rightsopenAccesspor
dc.titleInnovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substancespor
dc.typearticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
000542309.pdf
Size:
1.17 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
3.89 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DCMS - Artigos em Livros de Actas/Proceedings
driver